Medicine for Humanity – Trademark Portfolio
Entity Type: 03
Medicine for Humanity holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MEDICINE FOR HUMANITY. The owner is based in Malibu, CA.
23823 Malibu Rd. Suite 50-299
Malibu, CA 90265
Showing of trademarks Trademarks
Trademark Classifications
Medicine for Humanity's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Medicine for Humanity have?
Medicine for Humanity has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 2 cancelled.
What trademark classes does Medicine for Humanity file in?
Medicine for Humanity files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Medicine for Humanity's most well-known trademarks?
Medicine for Humanity's registered trademark portfolio includes well-known marks such as MEDICINE FOR HUMANITY. These are among 3 currently registered trademarks in the portfolio.
What is Medicine for Humanity's trademark registration success rate?
Medicine for Humanity has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.